Advertisement

Neuro-Oncology pp 205-207 | Cite as

The Potential Role of Lonidamine in the Combined Treatment of Malignant Gliomas. A Randomized Study

  • C. M. Carapella
  • M. G. Paggi
  • F. Calvosa
  • F. Cattani
  • A. Floridi
  • B. Jandolo
  • L. Raus
  • A. Riccio
Part of the Developments in Oncology book series (DION, volume 66)

Abstract

Lonidamine (LND) is a drug that interferes with energy metabolism of cancer cells. In such way LND impairs energy-requiring processes, as recovery from potentially lethal damage, induced by radiotherapy, hyperthermia and some cytotoxic drugs. Its activity appears interesting enough to suggest clinical studies on its potentially radio-enhancing effect. A randomized study started in November 1983, to evaluate the activity of LND in association with radiotherapy as first line treatment in malignant gliomas, after surgical procedure. LND was also used in association with Lomustine (CCNU) at the moment of documented clinical and neuroradiological recurrence. Present preliminary results are described.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1-.
    Graham, J.F. Cummins, J.F. Smith, B.H. et al. (1985) Regulation of hexokinase in cultured gliomas. Neurosurgery 17, 537–542.PubMedGoogle Scholar
  2. 3-.
    Hahn, G.M. Van Kersen, I. Silvestrini, B. (1984) Inhibition of the recovery from potentially lethal damage by lonidamine. Br J Cancer 50,657–660.CrossRefGoogle Scholar
  3. 6-.
    Floridi, A. Gambacurta, A. Bagnato, A. et al. (1988) Modulation of Adriamycin uptake by lonidamine in Ehrlich ascites tumor cells. Exp Mol Pathol 49, 421–431.PubMedGoogle Scholar
  4. 8-.
    Rosbe, K.W. Brann, T.W. Holden, S.A. et al. (1989) Effect of Lonidamine on the cytotoxicity of four alkylating agents in vitro. Cancer Chemother Pharmacol 25, 32–36.PubMedCrossRefGoogle Scholar
  5. 9-.
    Floridi, A. Personal Communication.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1991

Authors and Affiliations

  • C. M. Carapella
    • 1
  • M. G. Paggi
    • 1
  • F. Calvosa
    • 1
  • F. Cattani
    • 1
  • A. Floridi
    • 1
  • B. Jandolo
    • 1
  • L. Raus
    • 1
  • A. Riccio
    • 1
  1. 1.“Regina Elena” National Cancer InstituteRomaItaly

Personalised recommendations